Financial Architects, Inc Vericel Corp Transaction History

Financial Architects, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $52,535 - $66,115	-3,500 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$16.23 - $20.29 $56,805 - $71,015	3,500 New	3,500 $61,000
Q1 2019 May 03, 2019	SELL	$16.23 - $20.29 $64,920 - $81,160	-4,000 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$10.77 - $18.44 $43,080 - $73,760	4,000 New	4,000 $69,000

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.